{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:13:13Z","timestamp":1789024393307,"version":"build-2803163510"},"reference-count":19,"publisher":"Norwegian Medical Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskriftet"],"published-print":{"date-parts":[[2009]]},"DOI":"10.4045\/tidsskr.09.35002","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T06:58:26Z","timestamp":1232434706000},"page":"101-104","source":"Crossref","is-referenced-by-count":21,"title":["Risikofaktorer for hepatitt C-smitte blant spr\u00f8ytemisbrukere"],"prefix":"10.4045","volume":"129","author":[{"given":"Olav","family":"Dalgard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atle","family":"Egeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Ervik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Vilimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Skaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Steen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"1792869_ref_1","unstructured":"World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 1999; 74: 425\u2009\u2013\u20097."},{"key":"1792869_ref_2","doi-asserted-by":"crossref","unstructured":"Hagan H. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149: 203\u2009\u2013\u200913.","DOI":"10.1093\/oxfordjournals.aje.a009792"},{"key":"1792869_ref_3","first-page":"821","volume":"111","author":"Kielland","year":"1991","journal-title":"Tidsskrift for Den norske legeforening"},{"key":"1792869_ref_4","doi-asserted-by":"crossref","unstructured":"Dalgard O, Jeansson S, Skaug K et al. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003; 38: 864\u2009\u2013\u200970.","DOI":"10.1016\/S0168-8278(03)80729-8"},{"key":"1792869_ref_5","doi-asserted-by":"crossref","unstructured":"Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26 (suppl 1): 21\u2009\u2013\u20098.","DOI":"10.1002\/hep.510260704"},{"key":"1792869_ref_6","unstructured":"Blystad H, Svendsen PK. Hepatitt C 10 \u00e5r etter. MSIS-rapport nr. 1\/2000. Oslo: Nasjonalt folkehelseinstitutt, 2000."},{"key":"1792869_ref_7","unstructured":"Blystad H, Nilsen \u00d8. Stoffmisbrukere og infeksjoner. MSIS-rapport nr. 48\/2000. Oslo: Nasjonalt folkehelseinstitutt, 2000."},{"key":"1792869_ref_8","doi-asserted-by":"crossref","unstructured":"Crofts N, Jolley D, Kaldor J et al. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51: 692\u2009\u2013\u20097.","DOI":"10.1136\/jech.51.6.692"},{"key":"1792869_ref_9","doi-asserted-by":"crossref","unstructured":"Hagan H, Thiede H, Weiss NS et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001; 91: 42\u2009\u2013\u20096.","DOI":"10.2105\/AJPH.91.1.42"},{"key":"1792869_ref_10","doi-asserted-by":"crossref","unstructured":"Garfein RS, Vlahov D, Galai N et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86: 655\u2009\u2013\u200961.","DOI":"10.2105\/AJPH.86.5.655"},{"key":"1792869_ref_11","doi-asserted-by":"crossref","unstructured":"Crofts N, Caruana S, Bowden S et al. Minimising harm from hepatitis C virus needs better strategies. BMJ 2000; 321: 899.","DOI":"10.1136\/bmj.321.7265.899"},{"key":"1792869_ref_12","doi-asserted-by":"crossref","unstructured":"De P, Roy E, Boivin JF et al. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat 2008; 15: 279\u2009\u2013\u200992.","DOI":"10.1111\/j.1365-2893.2007.00942.x"},{"key":"1792869_ref_13","doi-asserted-by":"crossref","unstructured":"Vandelli C, Renzo F, Romano L et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004; 99: 855\u2009\u2013\u20099.","DOI":"10.1111\/j.1572-0241.2004.04150.x"},{"key":"1792869_ref_14","doi-asserted-by":"crossref","unstructured":"McMahon JM, Pouget ER, Tortu S. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. J Infect Dis 2007; 195: 1572\u2009\u2013\u200981.","DOI":"10.1086\/516785"},{"key":"1792869_ref_15","doi-asserted-by":"crossref","unstructured":"Crofts N, Stewart T, Hearne P et al. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995; 310: 285\u2009\u2013\u20098.","DOI":"10.1136\/bmj.310.6975.285"},{"key":"1792869_ref_16","unstructured":"Moloughney BW. Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now? CMAJ 2001; 165: 445\u2009\u2013\u200951."},{"key":"1792869_ref_17","doi-asserted-by":"crossref","unstructured":"Miller M, Mella I, Moi H et al. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr 2003; 33: 373\u2009\u2013\u20099.","DOI":"10.1097\/00126334-200307010-00012"},{"key":"1792869_ref_18","unstructured":"Bretteville-Jensen AL, Amundsen EJ. Omfang av spr\u00f8ytemisbruk i Norge. Rapport nr. 5\/2006. Oslo: Statens institutt for rusmiddelforskning, 2006."},{"key":"1792869_ref_19","doi-asserted-by":"crossref","unstructured":"Dalgard O, Egeland A, Skaug K et al. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004; 39: 74\u2009\u2013\u200980.","DOI":"10.1002\/hep.20014"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T07:02:08Z","timestamp":1558076528000},"score":1,"resource":{"primary":{"URL":"http:\/\/tidsskriftet.no\/article\/1792869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":19,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.35002","relation":{},"ISSN":["0029-2001"],"issn-type":[{"value":"0029-2001","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}